| 
                    
                      |  |  
                      | K. Barry Sharpless, left, receives 
                        the Nobel Prize for Chemistry from Swedish king Carl XVI 
                        Gustav during the award ceremony at the concert hall in 
                        Stockholm, Sweden, on Monday, December 10, 2001. AP/WIDE 
                        WORLD PHOTOS |     Year in ReviewBy Mika Ono 
                   When we look back at 2001, we will no doubt remember national 
                    eventsthe devastating attacks of September 11 and the 
                    country's war on terrorism. But the local news was not all 
                    bleak. In fact, The Scripps Research Institute (TSRI) provided 
                    much to celebrate. 
                    This week, K. Barry Sharpless, W.M. Keck Professor at TSRI's 
                    Skaggs Institute for Chemical Biology, was in Stockholm to 
                    receive the Nobel Prize in Chemistry from the King of Sweden 
                    Carl XVI Gustaf in a ceremony with much pageantry. Winning 
                    the prize with two other chemists for work on the development 
                    of catalytic asymmetric synthesis, Sharpless became the second 
                    Nobel laureate on campus with Gerald Edelman, chair of the 
                    Department of Neurobiology. 
                    Based on the exemplary work of its researchers, TSRI was 
                    ranked the most influential institution in the world in the 
                    physical sciences (which includes the fields of chemistry 
                    and physics), tenth in the medical sciences, and eleventh 
                    in the biological sciences by the Institute for Scientific 
                    Information. Examples of groundbreaking research from TSRI 
                    labs this year are numerous:
                   
                     TSRI investigator Geoffrey Chang published an x-ray crystal 
                      structure that provides the first detailed glimpse of a 
                      membrane transporter protein, a finding that could be useful 
                      for improving cancer therapy and fighting antibiotic-resistant 
                      bacteria. 
 
 Investigators Erica Ollmann Saphire, Dennis Burton, and 
                      Ian Wilson were among the researchers who published the 
                      structure of an antibody that effectively neutralizes human 
                      immunodeficiency virus (HIV), a necessary first step in 
                      the development of an effective vaccine.
 
 Investigators Dennis Burton and Anthony Williamson published 
                      work that describes an antibody that arrests prion infections 
                      in cell culture, a finding that may lead to a treatment 
                      for mad cow disease. 
 
 Investigators Peter Schultz and Paul Schimmel published 
                      two separate papers in which they were the first to describe 
                      methods of engineering bacterial cells to encode "unnatural" 
                      proteins, which incorporate novel amino acids not found 
                      in nature.
 
 Professor M. Reza Ghadiri and colleagues published a 
                      paper that described a dramatically new approach for designing 
                      drugs to combat such problems as infections with antibiotic-resistant 
                      bacteria.
 
 Investigator Kim Janda designed a new vaccine against 
                      cocaine that could become a valuable tool in treating addiction. 
                      This and other research was made possible by the generous 
                    support of individual donors, private foundations, and the 
                    National Institutes of Health (NIH). Notable new awards from 
                    the NIH this year included grants to a consortium of alcohol 
                    researchers led by TSRI Professor George Koob, a Consortium 
                    for Functional Glycomics at TSRI led by Professor James Paulson, 
                    and a new Core Center for Vision Research at TSRI led by Associate 
                    Professor Martin Friedlander. In addition, a gift from Helen 
                    L. Dorris made possible the new Helen L. Dorris Institute 
                    for the Study of Neurological and Psychiatric Disorders of 
                    Children and Adolescents. 
                    The face of the campus changed in 2001. A 54,000-square-foot 
                    building, The Institute for Childhood and Neglected Diseases, 
                    opened its doors on the east side of campus. The world's most 
                    powerful NMR magnet was delivered to TSRI in June. And a new 
                    sculpture by TSRI Trustee John Safer, "The Flame of Knowledge," 
                    was dedicated in memory of Norton Gilula, the first dean of 
                    the graduate program and chair of the Department of Cell Biology.
                    Throughout the year, TSRI continued to fulfill its mission 
                    as an educational institution. In May, 21 students graduated 
                    from TSRI's two Ph.D. programsboth of which are currently 
                    ranked in the top ten in the nation by U.S. News & World Report. 
                    In August, 37 new students entered the programs. 
                    TSRI's Science Outreach Program, which was presented with 
                    an Exemplary Partnership Award from the San Diego City Schools 
                    in June, continued to promote science education in the community 
                    through seminars and internship programs for teachers and 
                    middle-school, high-school, and undergraduate students. The 
                    program received major gifts this year from Chair of the TSRI 
                    Board of Trustees John Diekman and his wife Susan, and The 
                    William Randolph Hearst Foundation.
                    Indeed, TSRI provided much welcome news in 2001. 
                    
                     
                     
                    
                    
    |        |